HuGE Literature Finder
Records
1
-
5
Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation. Cancer medicine 2020 Jan . Ye Fugui, Huang Liang, Lang Guantian, Hu Xin, Di Genhong, Shao Zhimin, Cao Ayo |
Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China. International journal of cancer 2019 Feb . Deng Mei, Chen Hui-Hui, Zhu Xuan, Luo Meng, Zhang Kun, Xu Chun-Jing, Hu Kai-Min, Cheng Pu, Zhou Jiao-Jiao, Zheng Shu, Chen Yi-Di |
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients. PloS one 2016 11 (6): e0156789. Zhong Xiaorong, Dong Zhengwei, Dong Hua, Li Jiayuan, Peng Zuxiang, Deng Ling, Zhu Xuehua, Sun Yun, Lu Xuesong, Shen Fuxiao, Su Xinying, Zhang Liying, Gu Yi, Zheng Ho |
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. The Lancet. Oncology 2015 Jan 16 (1): 87-97. Oza Amit M, Cibula David, Benzaquen Ana Oaknin, Poole Christopher, Mathijssen Ron H J, Sonke Gabe S, Colombo Nicoletta, Špa?ek Ji?í, Vuylsteke Peter, Hirte Holger, Mahner Sven, Plante Marie, Schmalfeldt Barbara, Mackay Helen, Rowbottom Jacqui, Lowe Elizabeth S, Dougherty Brian, Barrett J Carl, Friedlander Micha |
Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study. Frontiers in oncology 2013 3 206. Tian Chunqiao Q, Darcy Kathleen M, Krivak Thomas C, Deloia Julie A, Armstrong Deborah, Davis Warren, Zhao Hua, Moysich Kirsten, Ambrosone Christine |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: